DEA Approves Synthetic Cannabis #Syndros As Schedule II

The DEA has classified Syndros, Insys Therapeutics’ synthetic marijuana product that mirrors compounds seen in the cannabis plant, as Schedule II. #deepweb #darknet #darkweb
https://goo.gl/mBeJEs